BMC Pharmacology and Toxicology: Assessment of biosafety and toxicity of hydrophilic gel for implantation in experimental in vitro and in vivo models

26.06.2022

BMC Pharmacology and Toxicology: Assessment of biosafety and toxicity of hydrophilic gel for implantation in experimental in vitro and in vivo models

Synopsis: Useful articles

The assessment of biosafety of pharmacologically active substances is crucial for determining the feasibility of their medical use. There are controversial issues regarding the use of substances of different origins as implants.
The journal BMC Pharmacology and Toxicology published an article with a research on this topic.
Journal BMC Pharmacology and Toxicology is an open access, peer-reviewed journal that considers articles on all aspects of chemically defined therapeutic and toxic agents. The journal welcomes submissions from all fields of experimental and clinical pharmacology including clinical trials and toxicology.
Our product Injection implant Hydrophilic gel – Activegel became a participant in this research.
You can get the article «Assessment of biosafety and toxicity of hydrophilic gel for implantation in experimental in vitro and in vivo models» by writing to us in e-mail.

BMC Pharmacology and Toxicology: Assessment of biosafety and toxicity of hydrophilic gel for implantation in experimental in vitro and in vivo models
BMC Pharmacology and Toxicology: Assessment of biosafety and toxicity of hydrophilic gel for implantation in experimental in vitro and in vivo models

Feedback form

Any questions?

We are always open to questions and suggestions. Leave a request in the feedback form or call us

Open